Covid-19 | Regulatory body nudges insurers to facilitate policyholders’ vaccination

[ad_1]

Read More/Less


IRDAI has asked insurers to make special arrangements to facilitate eligible category among their policyholders to get vaccinated as a group or individually.

Nudging insurance companies to join the COVID-19 vaccination drive and create awareness among policyholders, the Insurance Regulatory and Development Authority of India (IRDAI) on Friday directed them to make special arrangements to facilitate inoculation of the eligible people at government or private hospitals.

IRDAI had sent instructions to the insurers on March 3. However, it communicated to them again on Friday (March 19 ) through a press release on its website.

The government’s national programme for vaccination against COVID-19 for 60 years old and above and those above 45 years of age with comorbidities started on March 1, 2021.

The Ministry of Health and Family Welfare has issued guidelines for vaccination of eligible citizens.

All the insurers are requested to join this national effort, IRDAI said in a communication to all the insurance companies.

IRDAI had issued instructions to insurers to facilitate vaccination programme for their policyholders through a communication on March 3, 2021.

In the letter, IRDAI asked them to make special arrangements to facilitate eligible category among their policyholders to get vaccinated as a group or individually either at a government facility of private facilities as per the option of the policyholders.

“First, insurers may create awareness about vaccination among the policyholders through effective communication via SMS or email. Secondly, they may assist the policyholder as a group to get vaccinated in an orderly manner by assisting them and making advance arrangement through pre booking slots,” the letter said.

Thirdly, the policyholders may be reminded for the second shot of vaccine in time, it added.

IRDAI has also asked the insurers to give adequate publicity on the process of registration for vaccination programme and special arrangements made if any for policyholders so that maximum number of people can be immunised.

Further, similar arrangements may be made for all the employees of the insurer and also all the agents so that they can be made immune to COVID-19 infection, IRDAI said.

The regulator has asked the insurance companies to inform it at the earliest about the action taken in this matter.

Those visiting government hospitals for the immunisation are provided the vaccine free of cost. While the designated private hospitals charge it at a rate specified by the government.

The instructions do not apply on AIC and ECGC — the two specialised government owned insurance firms that cater to crop insurance and export credit insurance, respectively.

[ad_2]

READ FULL ARTICLE HERE

Morning Digest: Roads to be freed of toll booths in a year, says Nitin Gadkari; EU drug regulator backs AstraZeneca vaccine against COVID-19 after safety investigation, and more

[ad_1]

Read More/Less


India will implement a GPS-based toll collection system and do away with all toll booths within a year, Union Minister for Road Transport and Highways Nitin Gadkari informed the Lok Sabha on Thursday. He also shared details of the vehicle scrapping policy, first announced in the Union Budget for 2021-22, according to which the automobile industry in India will see a jump in turnover to ₹10 lakh crore from ₹4.5 lakh crore.

Chief Justice of India Sharad A. Bobde agreed with advocate Prashant Bhushan on Thursday to urgently hear a plea by NGO Association for Democratic Reforms to stay the sale of a new set of electoral bonds on April 1, before Assembly elections in crucial States such as West Bengal and Tamil Nadu.

Top U.S. and Chinese officials offered sharply different views of the world on March 18 as the two sides met face-to-face for the first time since President Joe Biden took office. In unusually pointed remarks for a staid diplomatic meeting, Secretary of State Antony Blinken and Chinese Communist Party foreign affairs chief Yang Jiechi took aim at each other’s policies at the start of two days of talks in Alaska.

The EU’s drug watchdog said on March 18 it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.

The Rajya Sabha on Wednesday passed the Insurance Amendment Bill 2021 that increases the maximum foreign investment allowed in an insurance company from 49% to 74%, amid criticism from the Opposition parties on the clause enabling “control and ownership” by foreign investors.

The Supreme Court on Wednesday forbade judges from making gender stereotypical comments like “’good women are sexually chaste”, women who drink and smoke ‘ask’ for sexual advances or presume that a sexually active woman consented to rape while hearing cases of sexual offence.

Union Communications and Information Technology Minister Ravi Shankar Prasad said on Thursday that climate activist Disha Ravi’s arrest was based on law and order and it is under judicial process. He added that the House should consider “should some people abuse social media internationally to defame India to promote secessionism.”

Former Chief Economic Advisor (CEA) Arvind Subramanian resigned from Ashoka University on Thursday, days after noted columnist and political commentator Pratap Bhanu Mehta’s exit. In his resignation letter, Dr. Subramanian, said he had been “devastated” by “the circumstances involving the ‘resignation’ of Professor Pratap Bhanu Mehta” two days earlier.

In a major embarrassment to the Bharatiya Janata Party (BJP), two candidates announced by the party on Thursday for the Assembly polls from Kolkata have refused to contest on the party’s ticket.

The Supreme Court on Thursday stayed suo motu proceedings before the Delhi High Court on the administration of COVID-19 vaccine and transferred the case to itself. A Bench led by Chief Justice of India Sharad A. Bobde said a similar case concerning the vaccination drive was already pending in the Supreme Court, and the case from the Delhi High Court could be heard along with it.

The Supreme Court on Thursday agreed to urgently hear a plea to release and protect over 150 Rohingya refugees reportedly “detained” in Jammu. Chief Justice of India S.A. Bobde agreed to hear the application filed by a member of the Rohingya community, Mohammad Salimullah, represented by advocates Prashant Bhushan and Cheryl d’Souza, on April 25 (Thursday). Mr. Bhushan made an oral mention before the CJI for an early hearing.

The Lok Sabha on Thursday passed the supplementary demand for grants (second batch for 2020-21) but not before significant concerns raised by Opposition leaders on the government’s disinvestment and asset monetisation plans, and rising fuel prices.

If Ishan Kishan was unfortunate to be ruled out of the fourth T20I due to a groin strain, lady luck smiled on his replacement Suryakumar Yadav. The Mumbai cricketer, dropped for the previous outing after not having faced a ball on his debut in the second T20I, grabbed his chance and made it count.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus | COVID-19 vaccine rollout needs course correction in the face of resurgence

[ad_1]

Read More/Less


The recent rise in COVID 19 cases in six states, accounting for 85% of reported new cases, is disturbing. The concerned State Governments and the Union Ministry of Health need to seriously soul search and quickly arrive at a plan of action to quell the resurgence by vaccination. The resurgence is most likely due to: the general public throwing caution to the wind – discarding the disciplined use of masks, hand hygiene and physical distancing; and engaging in activities leading to mass gatherings – including weddings and funerals – that are conducive to spreading the virus. Opening up of transport services in general and suburban train services in Mumbai in particular, would have contributed to the resurgence.

Regulatory agency authorised emergency use of two COVID-19 vaccines on January 3. On January 16, both were made available to healthcare professionals, the first priority, followed by those in essential services. From March 1, the second phase has begun when senior citizens and those above 45 with co-morbidities are the next priority for vaccination; the Government is expanding the coverage in a phased manner, starting with selected segments of society and expanding to cover more. India’s COVID vaccination programme will be world’s second largest because we have the second largest population in the world. However in the face of the resurgence of cases in six states, should there not be a change in strategy?

The right goals

Setting goals for wide vaccination coverage systematically is an administrative activity. Health management approach would have a different goal. Since health management has two arms, public health and healthcare, each would have its own goal – a healthcare goal and a public health goal.

The healthcare goal is to mitigate adverse disease outcomes, the hierarchy is, for preventing: death; disease becoming severe to require intensive care; hospitalisation per se and finally, symptomatic disease. Here, need-based vaccine coverage has to begin on the basis of vulnerability to these outcomes – hence vaccination should be prioritised for oldest down to 65 years; all below 65 with co-morbidity – obesity, hypertension, chronic heart, lung, kidney or liver disease, people with malignancies whether or not on treatment, etc.

The public health goal is to reduce the speed of coronavirus transmission, thereby reducing the community burden of COVID-19. For this vaccination drive should be targeted to the six states in which the speed of transmission is highest – Maharashtra, Punjab, Haryana, Gujarat, Madhya Pradesh and Delhi. In these States, vaccination ought to be undertaken on war footing, even taking the help of the army, for implementation. While vaccine-war progresses in these six States, other States should continue targeted healthcare vaccination of the elderly and the vulnerable.

Economic impact

To overcome the economic impact of the pandemic, civil administration should set up its own independent goals. Priority ought to be for step-wise and safe revival of all stalled activities in various systems – education, law and order, transport, sanitation and general administration. A systematic targeted vaccination plan and platform should be designed for this purpose in relevant locations. Economic revival demands the opening up of all industrial and agricultural activities, and India’s human personnel in these areas ought to be vaccinated systematically.

The attempt to meet this demand by having vaccination centres working 24/7 is a step in the right direction, but more innovative steps need to be taken in order to reach vaccination to the people in rural India. Countries like the U.S. have started using mobile vaccination centres and have established vaccination centres in supermarkets to rapidly cover the entire population. In India a similar approach, especially mobile vaccination units, can rapidly cover many villages.

Even now it is not too late to define goals for public health, healthcare and the administrative segment and plan appropriate strategy and tactics to achieve their respective goals. The three should function in a well-oiled, co-ordinated and seamless manner to achieve their targets.

The public, including healthcare professionals, apparently misunderstood that the vaccine roll-out was premature without stating its purpose or it was for political reasons – to showcase one of the world’s largest vaccination programmes by making it a well-orchestrated drill. But when unaccompanied by sharing of authentic and authoritative information, it led to wide-spread vaccine hesitancy. Public health programmes rely heavily on information-education-communication – after all if people understand that vaccination is for their own good and for the benefit of the entire nation, they will willingly cooperate.

Education

So, concurrently with planning the revised strategy, there should be a health education blitzkrieg about the benefits of the vaccination for the individual and for the community – so that people may knowingly and willingly participate in it. It can easily be accomplished since we are well-versed in vigorous campaigns for various purposes.

If India demonstrates its ability to set-up this model, and execute the world’s second largest vaccination programme to perfection, it will be worthy of emulation in all countries of the world.

(T. Jacob John is retired professor of clinical virology, Christian Medical College, Vellore. M.S. Seshadri is retired professor of medicine (endocrinology), CMC and medical director of Thirumalai Medical Mission Hospital, Ranipet. )

This story is available exclusively to The Hindu subscribers only.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

May not be new wave yet, vaccination plus Covid protocol key to quell surge in cases: Scientists | India News – Times of India

[ad_1]

Read More/Less


NEW DELHI: With India recording the highest number of daily novel coronavirus cases in 83 days on Saturday, the country could be heading towards a new wave that scientists say can be quelled by vaccinating the maximum number of people and following Covid-appropriate behaviour.
The Union health ministry reported 24,882 fresh Covid-19 infections, up from 23,285 the day earlier and in keeping with a graph steadily inching upwards. This is the highest daily rise since December 20 when 26,624 new infections were recorded.
As red flags went up, the jury was out on whether it constituted a new wave of the pandemic. Scientists grappled with the why and how of the surge in cases but were agreed that adherence to Covid-19 protocols and escalating the vaccination drive to cover more people were necessary to control the rising trajectory of the disease.
Anurag Agarwal, director of the CSIR-Institute of Genomics and Integrative Biology, said scientists at his institute are trying to understand if the rise in cases is due to more-transmissible variants of the virus or due to a lapse in precautionary measures followed by people. Though there is no clarity if a new wave of the pandemic is currently underway, some things are certain.
“Covid appropriate behavior and vaccination remain our best ways to stop the pandemic,” Agarwal told PTI.
There could possibly be a silver line somewhere.
According to Monica Gulati, senior dean and head of faculty of Applied Medical Sciences, Lovely Professional University, India’s rising curve is not very high unlike other countries where new strains have been found, indicating that the prevalent strain is not very infectious.
She also said the current rise in reported coronavirus infections could be due to the spread of new variants as well as the casual attitude of the general public. Gulati explained that the current surge in cases “is very well separated and shows a less steep rise from the previous ones indicating a change in the causative factor”.
“While in countries where the new strains are found to be more lethal than the original strains, the new wave is much steeper and higher as compared to the previous one. In India, the slope of the rising curve is not very high as yet which may be attributed to a number of factors, including a break in the propagation chain due to high rate of vaccination and low infectivity of the prevalent strain,” Gulati told PTI. Other scientists took a grimmer view of the situation.
The seven-day average of new cases of infection has risen by 67 per cent in India — from 10,988 cases a day for the week leading to February 11, to 18,371 average daily cases for the week ending on Wednesday, The positivity rate, which is the fraction of coronavirus tests conducted across the country that are positive for infection, has also been steadily increasing over the last month. While it was only 1.6 per cent for the week leading to February 14, currently 2.6 per cent of all tested samples are positive for the coronavirus infection — a rise by one whole percentage point within a month.
Rakesh Mishra, director of the CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), warned that there could be a new wave if the current trends continue and new homegrown variants of the virus may emerge.
“There is a possibility of another wave. Right now this is happening already in a couple of states, including Maharashtra, in a major way. But this is avoidable with exceptional advisory and continuation of Covid appropriate behaviour,” Mishra told PTI.
“Currently the rise in cases is happening in multiple cities, across states, and it doesn’t look like a new variant is responsible for all these surges but one common feature in all these places is lack of Covid appropriate behaviour. And if this continues, it may even lead to new variants emerging in India,” he added. Virologist Upasana Ray concurred that it may be too early to say if a second wave is currently underway but said the trends definitely point to a localised surge.
“Although it may or may not turn out to be a second wave, we should consider it a potential concern and be prepared for the worst,” Ray, a senior scientist with CSIR-Indian Institute of Chemical Biology, told PTI.
“We hear about new variants. Whether or not any of them is responsible, that part is not established yet. However, keeping an eye on home grown mutants would be important,” she added.
Ray said there is widespread pandemic fatigue, due to which people are no longer following Covid-19 appropriate behavior like masking up, social distancing, and maintaining hygiene as they did earlier.
The need of the hour is to revisit compliance with safety measures at all public places, she said.
“Then comes expediting vaccinations so that the immunity is achieved faster in the population and localised surges could die off due to decreased transmission rate. Also, rigorous screening and isolation are still important for keeping a check,” the virologist added.
Till 7 pm Thursday, over 2.6 crore Covid-19 vaccine doses were administered across the country. These included 72,16,759 (72.16 lakh) healthcare workers (HCWs) who have taken the first dose and 40,48,754 (40.48 lakh) HCWs who have taken the second dose, according to the Union Health Ministry.
Given the current rate of vaccination, Agarwal said, it would take a while for the country to build herd immunity, which is when a significant portion of the population builds immunity against the coronavirus and stops its chain of transmission. The need of the hour, Gulati said, is to dispel fear and scepticism among the general population with regard to vaccination. “As the vaccines being administered in India have been found to be both safe and effective, people must demonstrate their willingness to get vaccinated, especially the vulnerable groups,” she added.
“Since vaccination is voluntary and available at the rate of Rs 250 per jab, the onus is now on people to voluntarily get vaccinated to break the vicious cycle of infection.”
In her view, the current focus should be on ensuring that the maximum number of eligible people are vaccinated and to continue to observe all the precautionary measures till herd immunity is established. The Health Ministry’s data notes that six states — Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu — continue to report a high number of fresh Covid-19 cases and together account for 85.91 per cent of daily new cases in the country.
Expressing concern over the rise in active Covid-19 cases in these states, the Centre has advised people to be “careful and watchful” and not to lower their guard.
NITI Aayog member V K Paul earlier this week described the coronavirus situation, especially in Maharashtra, as “worrisome”. Paul advised that in districts where Covid-19 cases are seemingly on the rise, vaccination of eligible individuals should be intensified and prioritised.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus | India records 18,327 new COVID-19 infections, active cases rise again

[ad_1]

Read More/Less


The COVID-19 active caseload has increased to 1,80,304 which now comprises 1.61% of the total infections

India’s COVID-19 tally rose to 1,11,92,088 with over 18,000 fresh cases being reported in a span of 24 hours in the country after 36 days, while active cases registered an increase for the fourth consecutive day on March 6 and were recorded at 1,80,304, according to the Union Health Ministry.

The death toll reached 1,57,656 with 108 more fatalities, while a total of 18,327 new cases were registered in a day, the Ministry’s data showed.

On January 29, 18,855 new infections were recorded in a span of 24 hours after which the daily rise in fresh cases remained below 18,000.

The number of people who have recuperated from the disease surged to 1,08,54,128 which translates to a national COVID-19 recovery rate of 96.98%, while the case fatality rate stands at 1.41%.

The COVID-19 active caseload has increased to 1,80,304 which now comprises 1.61% of the total infections.

India’s COVID-19 tally had crossed the 20 lakh-mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one crore-mark on December 19.

According to the ICMR, 22,06,92,677 samples have been tested up to March 5 with 7,51,935 samples being tested on March 5.

The 108 new fatalities include 53 from Maharashtra, 16 from Kerala and 11 from Punjab.

A total of 1,57,656 deaths have been reported so far in the country, including 52,393 from Maharashtra followed by 12,513 from Tamil Nadu, 12,354 from Karnataka, 10,918 from Delhi, 10,275 from West Bengal, 8,729 from Uttar Pradesh and 7,172 from Andhra Pradesh.

The Health Ministry stressed that more than 70% of the deaths occurred due to comorbidities.

“Our figures are being reconciled with the Indian Council of Medical Research,” the Ministry said on its website, adding that State-wise distribution of figures is subject to further verification and reconciliation.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus Vaccine: Stop taking this common over-the-counter medication before getting the COVID vaccination | The Times of India

[ad_1]

Read More/Less


Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to relieve pain, decrease inflammation, and reduce high temperature. It is a common type of anti-inflammatory drug often used by people who are suffering from headaches, painful periods, sprains and strains, colds and flu and arthritis. However, these medications can hinder your body’s immune response system and will reduce the efficacy of the vaccination.

It takes time for our body to build protection after any vaccination. The same goes for the COVID-19 vaccine. Taking medicines like ibuprofen or acetaminophen before getting the shot could make it less effective as they can prevent your body from producing antibodies.

[ad_2]

READ FULL ARTICLE HERE

Over 1.8 crore vaccine doses administered in India | India News – Times of India

[ad_1]

Read More/Less


NEW DELHI: The cumulative number of Covid-19 vaccine doses administered in India has crossed 1.8 crore, the Union Health Ministry said on Friday.
These include 68,53,083 healthcare workers (HCWs) who were administered the 1st dose, 31,41,371 HCWs who were given the 2nd dose, 60,90,931 frontline workers (FLWs) who were given the 1st dose and 67,297 FLWs (2nd dose), 2,35,901 beneficiaries aged more than 45 years with specific co-morbidities (1st dose) and 16,16,920 beneficiaries aged more than 60 years.
Nearly 14 lakh (13,88,170) vaccine doses were given on Thursday, Day-48 of the vaccination drive (March 4)
The ministry said 10,56,808 beneficiaries were vaccinated across 16,081 sessions for 1st dose (HCWs and FLWs) and 3,31,362 HCWs and FLWs received 2nd dose of vaccine.
The 10,56,808 beneficiaries include 6,15,903 people aged over 60 and 92,109 individuals aged more than 45 years with specific co-morbidities (1st dose)
Six sates, Maharashtra, Punjab, Haryana, Gujarat, MP and Delhi, have reported high daily new cases in a span of 24 hours, the ministry said underlining 84.44% of the new cases reported in a span of 24 hours (16,838) are from these six states.
Maharashtra continues to report the highest daily new cases at 8,998. It is followed by Kerala with 2,616 while Punjab reported 1,071 new cases.
Eight states are displaying an upward trajectory in daily new cases, the ministry highlighted.
India’s total active caseload stands at 1.76 lakh (1,76,319) which comprises 1.58% of India total infections.
The ministry said that Kerala, Tamil Nadu and West Bengal have shown a reduction in the active cases in a span of 24 hours.
Maharashtra, Punjab, Madhya Pradesh, Haryana, Delhi and Gujarat display a rise in the active cases during the same time period.
Showing the change in number of active cases for states in the last one month, the ministry said Kerala, UP, West Bengal, Chhattisgarh and Tamil Nadu are the top 5 states showing a decline in active cases in the last one month, while Maharashtra, Punjab, Madhya Pradesh, Haryana and Delhi are the top 5 states showing a rise in active cases.
The ministry said 20 states and UTs have less than 1000 active cases. Arunachal Pradesh reported only 2 active cases.
The Cumulative Positivity Rate of the country shows a continuous decline and stands at 5.08%
Eight states display a weekly positivity rate higher than the national average (2.09%). Among them, Maharashtra stands out with a weekly positivity rate of 10.38%.
The ministry said 113 deaths were reported in a day.
Six states account for 88.5% of the new deaths. Maharashtra saw the maximum casualties (60). Punjab follows with 15 daily deaths. Kerala reported 14 deaths.
Eighteen states and UTs have not reported any Covid-19 deaths in a span of 24 hours. These are A&N Islands, Arunachal Pradesh, Assam, Chandigarh, Daman and Diu, Dadara and Nagar Haveli, Gujarat, Haryana, Himachal Pradesh, Ladakh (UT), Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Puducherry, Sikkim, Tripura and Uttarakhand.

[ad_2]

READ FULL ARTICLE HERE

Explained: Here’s When CO-WIN App Will Launch, How to Register for COVID-19 Vaccine in India

[ad_1]

Read More/Less


The government has announced that the COVID-19 vaccine tracking and registration app Co-WIN will also go live in India on March 1, the same day when the second phase of inoculation drive starts in the country for people above 60 years of age and those over 45 with co-morbidities. The second phase starts less than a month after the government commenced its vaccination programme for frontline health workers and select beneficiaries on January 16. The vaccination process in India is being monitored via the Co-WIN app and portal, available only to administrators and beneficiaries. Citizens who have received the two vaccine shots to date can get the COVID-19 vaccine certificate via the Co-WIN portal and Aarogya Setu app.

Currently, some details about the vaccination drive via Co-WIN remains unclear, and we’ll get a better picture once the app is available for all users. Meanwhile, News18 also spoke to RS Sharma, chairman of the Co-Win panel, to understand the government’s plan on the next phase of vaccination drive and its modalities.

How to register for the COVID-19 vaccine in India: RS Sharma, in the interview, said that eligible beneficiaries would be able to self-register from March 1 or March 2. Citizens can use portals such as the Co-WIN app, Aarogya Setu app or Co-WIN website (cowin.gov.in) for registration. Notably, there’s also a provision where people will have a walk-in system till the time the registration system is used by more and more people.

What is required for COVID-19 registration: The government explains that citizens will need to register on the Co-WIN app via their mobile number, following which they would receive an OTP. After registering on the app, users would need to provide information such as name, age, gender, and an identity document that needs to be carried to the vaccine centre. The Co-WIN app can register as many as four family members. As mentioned, the existing Aarogya Setu would also seemingly get the same benefits. Recently, the app got a dedicated CoWIN section that provides statistics and access to links where beneficiaries can receive certificates.

All about the Co-WIN app: The development over the COVID-19 vaccine tracker and registration, the Co-WIN app was announced last year. The government had then explained that citizens who are not frontline health workers would be able to register for the vaccine via the ‘Registration Module’ within the app. The admins via the ‘Administrator module’ will then track the information provided by citizens of India. The Vaccination module of the Co-WIN app will verify the beneficiary details and update vaccination status. The ‘Beneficiary Acknowledgement Module’ will send an SMS to beneficiaries and also generate QR-based certificates after one completes the vaccination process. Lastly, the Report Module will prepare reports of how many vaccine sessions have been conducted, how many people have attended those, how many people have dropped out etc.

Other details you need to know about the COVID-19 vaccine in India: RS Sharma has told NDTV that the Co-WIN app will not allow citizens to choose which vaccine they will get. They can choose the date and COVID-19 vaccine centre. Additionally, people aged above 45 years will have to upload a medical certificate mentioning their co-morbid conditions. The government is yet to specify the conditions that would be included in the over-45 age group with comorbidities.

Many private hospitals have also received certification to act as COVID-19 vaccine centres where they cannot charge more than Rs 250 per shot. COVID-19 vaccines are free of cost in government hospitals. Citizens who are not tech-savvy or do not own a smartphone can call the centre number — 1507. As mentioned, they can walk-in to the nearest centre and if there’s a vacancy.



[ad_2]

READ FULL ARTICLE HERE